Bausch + Lomb Corporation
Common Stock · NYSE
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on BLCO yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Bausch + Lomb reported that its post-surgical ocular pain asset failed to meet the main goal of a phase 2 trial. The result is a setback for the pipeline and a point of interest for holders of the stock.
No SEC financials for BLCO yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.